---
layout: minimal-medicine
title: Cytarabine (Conventional)
---

# Cytarabine (Conventional)
### Generic Name
Cytarabine (Conventional)

### Usage
Cytarabine (conventional) is a chemotherapy medication primarily used to treat various types of leukemia.  Its main application is in the induction of remission in acute myeloid leukemia (AML), often in combination with other chemotherapy drugs. It's also used in the treatment of acute lymphoblastic leukemia (ALL), particularly in relapsed or refractory cases, and in chronic myeloid leukemia (CML) that has progressed to the blast phase.  A significant secondary use is in the prophylaxis (prevention) and treatment of meningeal leukemia, which is leukemia affecting the fluid surrounding the brain and spinal cord.  Numerous off-label uses exist, including its role in various combination chemotherapy regimens for other types of leukemia and lymphomas.  These off-label uses often involve specific dosing schedules and combinations with other drugs.


### Dosage
The dosage of cytarabine varies greatly depending on the specific condition being treated, the patient's age and weight, and the chosen treatment regimen.  Dosage is often calculated based on body surface area (BSA) or body weight (BW). There are many different dosage regimens, so the following are merely examples and should not be considered complete:


**Adults:** Dosages range from low-intensity subcutaneous (SubQ) administration of 20 mg/m²/day to high-dose intravenous (IV) regimens exceeding 3000 mg/m² every 12 hours.  For AML remission induction, common IV regimens involve continuous infusions of 100-200 mg/m²/day for 7 days.  Consolidation and salvage therapies often employ higher doses and different schedules.  Intrathecal administration (directly into the cerebrospinal fluid) is used for meningeal leukemia, with dosages typically ranging from 5 to 75 mg/m².


**Children:** Pediatric dosages are also highly variable, often expressed as mg/kg/day or mg/m²/day. Similar to adult treatment,  IV infusions are common for AML, ALL, and other leukemias, with dosages and schedules adapted for a child's size and the specific treatment protocol.  Intrathecal administration is also used for meningeal leukemia, with dosage adjusted for body surface area.


**Important Note:**  The information above represents a small fraction of the possible dosing regimens for cytarabine.  Precise dosing instructions must come from a qualified healthcare professional familiar with the specific condition, patient characteristics, and chosen treatment protocol.  This information should never substitute for a doctor's recommendations.


### Side Effects
Cytarabine can cause a range of side effects, varying in severity and frequency depending on the dosage and the patient’s individual response.


**Common Side Effects:**

* Nausea
* Vomiting
* Diarrhea
* Abdominal pain
* Mouth sores (mucositis)
* Hair loss (alopecia)
* Low blood cell counts (myelosuppression leading to anemia, leukopenia, and thrombocytopenia), increasing the risk of infection and bleeding.

**Serious but Less Common Side Effects:**

* Severe allergic reactions (anaphylaxis)
* Pancreatitis
* Hepatic veno-occlusive disease (liver damage)
* Neurotoxicity (nerve damage), especially with intrathecal administration
* Aseptic meningitis (inflammation of the membranes surrounding the brain and spinal cord)
*  Reversible posterior leukoencephalopathy syndrome (RPLS, brain disorder)


If any concerning side effects occur, immediate medical attention is crucial.


### How it Works
Cytarabine is an antimetabolite, specifically a pyrimidine analog.  It interferes with the synthesis of DNA, a crucial component of cell replication.  Once inside a cell, cytarabine is converted into its active form, which incorporates into the DNA structure. This prevents further DNA synthesis and repair, ultimately leading to cell death.  The drug is particularly effective against cells that are actively dividing, making it a useful tool in treating cancers such as leukemia.


### Precautions
* **Allergy:** Cytarabine is contraindicated in individuals with a known hypersensitivity to the drug or any of its components.
* **Bone Marrow Suppression:**  Cytarabine can severely suppress bone marrow function, leading to low blood cell counts. Regular blood tests are necessary to monitor this risk.
* **Liver and Kidney Function:**  Patients with pre-existing liver or kidney disease require careful monitoring, as cytarabine metabolism and excretion may be affected. Dose adjustments may be necessary.
* **Pregnancy and Breastfeeding:** Cytarabine is categorized as a pregnancy Category D drug, indicating a risk of fetal harm. Women of childbearing age should use effective contraception during treatment and avoid pregnancy. The effects of cytarabine on breastfeeding are unknown, and a healthcare provider should guide this decision.
* **Drug Interactions:** Cytarabine can interact with other medications.  Healthcare professionals must be informed of all other medications, including over-the-counter drugs and supplements, to minimize potential interactions.


### FAQs
* **Q: How is cytarabine stored?** A: Storage instructions vary by formulation, so always follow the directions on the medication label.  Generally, it should be kept at a controlled room temperature and protected from light and moisture.
* **Q:  How long does it take for cytarabine to work?** A: The effectiveness of cytarabine varies depending on the type and stage of the cancer being treated.  It is crucial to follow the treatment plan carefully and work closely with the healthcare team to monitor progress.
* **Q: What should I do if I miss a dose?** A: Never adjust the dosing schedule without consulting your doctor or pharmacist.  Missing doses can negatively impact treatment efficacy.
* **Q: Is cytarabine safe for everyone?** A: Cytarabine is a powerful chemotherapy drug, and its safety depends heavily on the individual's health status and the specific treatment plan.  Healthcare professionals thoroughly assess each patient's eligibility before starting treatment.
* **Q: Are there long-term effects associated with cytarabine?** A: Long-term effects are possible, particularly related to bone marrow suppression and increased risk of secondary cancers.  Regular follow-up care is crucial to manage these risks.

**Disclaimer:** This information is intended for educational purposes only and does not provide medical advice. Always consult with a healthcare professional for diagnosis and treatment of any medical condition.  The provided dosage information is not exhaustive and should not be used for self-medication.  Always follow the instructions provided by your physician or pharmacist.
